Study of gyrA S83R Mutation Rate in Vancomycin Resistant Entrococcus Faecium
Trends in Peptide and Protein Sciences,
Vol. 1 No. 4 (2017),
3 September 2017
,
Page 183-189
https://doi.org/10.22037/tpps.v1i4.18068
Abstract
Enterococci are among Gram-positive cocci and are common inhabitants of the human gastrointestinal tract and enough potent to cause serious infections such as bacteremia, urinary tract infections (UTIs) and endocarditis. Enterococci are not generally considered as highly infectious bacterium. However, the main reason for treatment failure in enterococcal infections is acquired resistance to glycopeptide antibiotics, specifically vancomycin. Most enterococcal infections in human such as gastroenteritis, intestinal infections, and endocarditis have been caused by E. faecalis and E. facieum. They are holding the second place of most frequent cause of hospital infections since 1990. In present study gyrA S83R polymorphism rate in vancomycin resistant Enterococcus faecium isolated from environment, food industries, and hospitals of Tehran were examined by ARMS-PCR technique. DNA was extracted from the bacterial colonies using standard column method, after separating the samples into two groups of antibiotic resistant and antibiotic susceptible by antibiogram test. A fragment of gyrA gene was amplified using PCR method to investigate point mutation of S83R position. ARMS-PCR technique was applied to detect the presence or absence of mutation using a set of specified primers which can be annealed when the mutation is present. The results were statistically analyzed by chi-square test (p < 0.05) using SPSS 19th version. The results showed that there was a significant correlation between the presences of S83R polymorphism with vancomycin resistance trait in Entrococcus faecium. Therefore, this technique could be used as a diagnostic tool to detect vancomycin resistance cases of E. faecium in patients and environment.
HIGHLIGHTS
•There is a strong association between the presence of point mutation at the position of Ser83 and vancomycin resistant phenotype.
•Resistance in Enterococcus spp. is highly mediated by mutations in gyrA gene which plays a major role in interaction with vancomycin.
•Vancomycin is the only drug that can be consistently relied on for the treatment of infections caused by multidrug resistant enterococci.
•VRE has presented a serious challenge for the Iranian medical community.
- Enterococcus faecium
- GyrA
- S83R
- Vancomycin
How to Cite
References
Ardebili, A., Lari, A. R., Beheshti, M. and E. R. Lari, (2015). "Association between mutations in gyrA and parC genes of Acinetobacter baumannii clinical isolates and ciprofloxacin resistance." Iranian Journal of Basic Medical Sciences, 18(6): 623-626.
Ballard, S. A., Pertile, K. K., Lim, M., Johnson, P. D. and M. L. Grayson, (2005). "Molecular characterization of vanB elements in naturally occurring gut anaerobes." Antimicrobial Agents and Chemotherapy, 49(5): 1688-1694.
Brinster, S., Posteraro, B., Bierne, H., Alberti, A., Makhzami, S., Sanguinetti M. and P. Serror, (2007). "Enterococcal leucine-rich repeat-containing protein involved in virulence and host inflammatory response." Infection and Immunity, 75(9): 4463-4471.
Cloete, T. E. (2003). "Resistance mechanisms of bacteria to antimicrobial compounds." International Biodeterioration & Biodegradation, 51(4): 277-282.
Dudley, M. N., Ambrose, P. G., Bhavnani, S. M., Craig, W. A., Ferraro, M. J., Jones, R. N., A. S. T. S. o. t. Clinical and L. S. Institute, (2013). "Background and rationale for revised Clinical and Laboratory Standards Institute interpretive criteria (breakpoints) for Enterobacteriaceae and Pseudomonas aeruginosa: I. Cephalosporins and aztreonam." Clinical Infectious Diseases, 56(9): 1301-1309.
Fatholahzadeh, B., Hashemi, F. B., Emaneini, M., Aligholi, M., Nakhjavani F. A. and B. Kazemi, (2006). "Detection of vancomycin resistant enterococci (VRE) isolated from urinary tract infections (UTI) in Tehran, Iran." DARU Journal of Pharmaceutical Sciences, 14(3): 141-145.
Fisher, K. and C. Phillips, (2009). "The ecology, epidemiology and virulence of Enterococcus." Microbiology, 155(6): 1749-1757.
French, G. (1998). "Enterococci and vancomycin resistance." Clinical Infectious Diseases, 27(Supplement_1): S75-S83.
Gardini, F., Martuscelli, M., Caruso, M. C., Galgano, F., Crudele, M. A., Favati, F., Guerzoni, M. E. and G. Suzzi, (2001). "Effects of pH, temperature and NaCl concentration on the growth kinetics, proteolytic activity and biogenic amine production of Enterococcus faecalis." International Journal of Food Microbiology, 64(1): 105-117.
Giedraitienė, A., Vitkauskienė, A., Naginienė, R. and A. Pavilonis, (2011). "Antibiotic resistance mechanisms of clinically important bacteria." Medicina, 47(3): 137-146.
Giraffa, G. (2002). "Enterococci from foods." FEMS Microbiology Reviews, 26(2): 163-171.
Hollenbeck, B. L. and L. B. Rice, (2012). "Intrinsic and acquired resistance mechanisms in enterococcus." Virulence, 3(5): 421-569.
Huycke, M. M., Sahm, D. F. and M. S. Gilmore, (1998). "Multiple-drug resistant enterococci: the nature of the problem and an agenda for the future." Emerging Infectious Diseases, 4(2): 239.
Jorgensen, J. H. and J. D. Turnidge, (2015). "Susceptibility test methods: dilution and disk diffusion methods. " Manual of Clinical Microbiology, Eleventh Edition, American Society of Microbiology: 1253-1273.
Korten, V., Huang, W. M. and B. E. Murray, (1994). "Analysis by PCR and direct DNA sequencing of gyrA mutations associated with fluoroquinolone resistance in Enterococcus faecalis." Antimicrobial Agents and Chemotherapy, 38(9): 2091-2094.
Lee, W. S. (1972). "Improved procedure for identification of group D enterococci with two new media." Applied Microbiology, 24(1): 1-3.
López, M., Tenorio, C., Del Campo, R., Zarazaga, M. and C. Torres, (2011). "Characterization of the mechanisms of fluoroquinolone resistance in vancomycin-resistant enterococci of different origins." Journal of Chemotherapy, 23(2): 87-91.
Makino, K., Shinagawa, H., Amemura, M. and A. Nakata, (1986). "Nucleotide sequence of the phoB gene, the positive regulatory gene for the phosphate regulon of Escherichia coli K-12." Journal of Molecular Biology, 190(1): 37-44.
Meziane-Cherif, D., Badet-Denisot, M. A., Evers, S., Courvalin, P. and B. Badeta, (1994). "Purification and characterization of the VanB ligase associated with type B vancomycin resistance in Enterococcus faecalis V583." FEBS Letters, 354(2): 140-142.
Michaux, C., Martini, C., Hanin, A., Auffray, Y., Hartke, A. and J.-C. Giard, (2011). "SlyA regulator is involved in bile salts stress response of Enterococcus faecalis." FEMS Microbiology Letters, 324(2): 142-146.
Miller, W. R., Munita, J. M. and C. A. Arias, (2014). "Mechanisms of antibiotic resistance in enterococci." Expert Review of Anti-Infective Therapy, 12(10): 1221-1236.
Morandi, S., Brasca, M., Andrighetto, C., Lombardi, A. and R. Lodi, (2006). "Technological and molecular characterisation of enterococci isolated from north–west Italian dairy products." International Dairy Journal, 16(8): 867-875.
Moreno, M. F., Sarantinopoulos, P., Tsakalidou, E. and L. De Vuyst, (2006). "The role and application of enterococci in food and health." International Journal of Food Microbiology, 106(1): 1-24.
Murray, B. E. (2000). "Vancomycin-resistant enterococcal infections." New England Journal of Medicine, 342(10): 710-721.
Nallapareddy, S. R., Sillanpää, J., Mitchell, J., Singh, K. V., Chowdhury, S. A., Weinstock, G. M., Sullam, P. M. and B. E. Murray, (2011). "Conservation of Ebp-type pilus genes among Enterococci and demonstration of their role in adherence of Enterococcus faecalis to human platelets." Infection and Immunity, 79(7): 2911-2920.
Ogier, J. C. and P. Serror, (2008). "Safety assessment of dairy microorganisms: the Enterococcus genus." International Journal of Food Microbiology, 126(3): 291-301.
Rathnayake, I., Hargreaves, M. and F. Huygens, (2011). "SNP diversity of Enterococcus faecalis and Enterococcus faecium in a South East Queensland waterway, Australia, and associated antibiotic resistance gene profiles." BMC Microbiology, 11(1): 201.
Rathnayake, I., Hargreaves, M. and F. Huygens, (2012). "Antibiotic resistance and virulence traits in clinical and environmental Enterococcus faecalis and Enterococcus faecium isolates." Systematic and Applied Microbiology, 35(5): 326-333.
Rice, L. B. (2006). "Antimicrobial resistance in gram-positive bacteria." American Journal of Infection Control, 34(5): S11-S19.
Sood, S., Malhotra, M., Das, B. and A. Kapil, (2008). "Enterococcal infections & antimicrobial resistance." Indian Journal of Medical Research, 128(2): 111-121.
Tenover, F. C. (2006). "Mechanisms of antimicrobial resistance in bacteria." The American Journal of Medicine, 119(6): S3-S10.
Teymournejad, O., Mohabati Mobarez, A. and R. Hosseini Doust, (2011). "Epidemiologic evaluation of Vancomycin Resistant genes in Enterococcus spp. isolated from clinical samples." Journal of Fasa University of Medical Sciences, 1(2): 1-6.
Weinstein, R. A. and M. K. Hayden, (2000). "Insights into the epidemiology and control of infection with vancomycin-resistant enterococci." Clinical Infectious Diseases, 31(4): 1058-1065.
Woodford, N. (1998). "Glycopeptide-resistant enterococci: a decade of experience." Journal of Medical Microbiology, 47(10): 849-862.
Wright, G. D. (2011). "Molecular mechanisms of antibiotic resistance." Chemical Communications, 47(14): 4055-4061.
- Abstract Viewed: 608 times
- PDF Downloaded: 202 times